4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-23-000102
Options or other derivatives
- President & CEO acquired 489,600 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Hirsch Andrew President & CEO | 2023-09-18 | Grant or award · Stock Option (Right to Buy) | +489,600 | 489,600 | D | ||
Loading xslF345X05/wk-form4_1695165874.xml…